{
 "PrintNo":"A9115","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2020-01-21T10:45:27.180256Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-21","Committee":"Insurance"}],
 "Actions":[{"Text":"REFERRED TO INSURANCE","Date":"2020-01-21","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":1115,"Name":"Melissa Miller","Short":"MILLER ML"}],"Title":"Relates to off-label drug usage",
 "Summary":"Requires insurers and pharmacy benefit managers provide coverage for off-label drug usage in certain circumstances.",
 "LawSection":"Insurance Law","LawCode":"Add ยง3114, Ins L; amd ยง280-a, Pub Health L",
 "ActClause":"AN ACT to amend the insurance law and the public health law, in relation to off-label drug usage"
}